Nav: Home

Antidepressant use increases hip fracture risk among elderly

January 11, 2017

Antidepressant use nearly doubles the risk of hip fracture among community-dwelling persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. The increased risk was highest at the beginning of antidepressant use and remained elevated even 4 years later. The findings were published in the International Journal of Geriatric Psychiatry.

For each person with Alzheimer's disease, two controls without the disease were matched by age and sex. Antidepressant use was associated with two times higher risk of hip fracture among controls. However, the relative number of hip fractures was higher among persons with Alzheimer's disease compared to controls.

The increased risk was associated with all of the most frequently used antidepressant groups, which were selective serotonin reuptake inhibitors (SSRI drugs), mirtazapine and selective noradrenaline reuptake inhibitors (SNRI drugs). The association between antidepressant use and the increased risk of hip fracture persisted even after adjusting the results for use of other medication increasing the risk of fall, osteoporosis, socioeconomic status, history of psychiatric diseases, and chronic diseases increasing the risk of fall or fracture.

Antidepressants are used not only for the treatment of depression, but also for the treatment of chronic pain and behavioral and psychological symptoms of dementia, including insomnia, anxiety and agitation. If antidepressant use is necessary, researchers recommend that the medication and its necessity be monitored regularly. In addition, other risk factors for falling should be carefully considered during the antidepressant treatment.

The study was based on the register-based MEDALZ cohort comprising data on all community-dwelling persons diagnosed with Alzheimer's disease in Finland between 2005-2011, and their matched controls. The study population included 50,491 persons with and 100,982 persons without the disease. The follow-up was 4 years from the date of Alzheimer's disease diagnosis or a corresponding date for controls. The mean age of the study population was 80 years.
-end-
Further information: Sanna Torvinen-Kiiskinen, PhD student, School of Pharmacy, University of Eastern Finland, Kuopio, +358 40 5021447, sanna.torvinen-kiiskinen@uef.fi

Original publication: Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease. Sanna Torvinen-Kiiskinen, Anna-Maija Tolppanen, Marjaana Koponen, Antti Tanskanen, Jari Tiihonen, Sirpa Hartikainen, Heidi Taipale. International Journal of Geriatric Psychiatry, 2017 Jan 5. doi: 10.1002/gps.4667. [Epub ahead of print]

University of Eastern Finland

Related Antidepressant Articles:

Analysis examines safety of antidepressant use during pregnancy
Use of fluoxetine -- the most commonly prescribed antidepressant -- during pregnancy is linked with a slightly increased risk of malformations in infants, according to a recent analysis of published studies.
Antidepressant may enhance drug delivery to the brain
New research from the National Institutes of Health found that pairing the antidepressant amitriptyline with drugs designed to treat central nervous system diseases, enhances drug delivery to the brain by inhibiting the blood-brain barrier in rats.
Novel mode of antidepressant action may help patients unresponsive to SSRIs
Research at Osaka University identified a novel mode of action for a potential antidepressant that also leads to nerve cell growth in the mouse hippocampus.
Antidepressant use during pregnancy not associated with increased risk of autism, ADHD in children
Two studies published by JAMA examine the risk of autism and other adverse birth outcomes among women who use antidepressants during pregnancy.
Most off-label antidepressant prescriptions lack strong scientific evidence
Most off-label antidepressant prescriptions lack strong scientific evidence, finds a study published by The BMJ today.
Brain scan before antidepressant therapy may predict response
A functional MRI brain scan may help predict which patients will respond positively to antidepressant therapy, according to a new study published in the journal Brain.
Antidepressant use increases hip fracture risk among elderly
Antidepressant use nearly doubles the risk of hip fracture among community-dwelling persons with Alzheimer's disease, according to a new study from the University of Eastern Finland.
Antidepressant effects of ketamine
New preclinical evidence was put forward by investigators in a series of presentations at the recent meeting of the American College of Neuropsychopharmacology suggest that the a metabolite of ketamine can produce antidepressant-like effects in a mouse model of depression.
New strategy for antidepressant therapies
Activated subclass of nerve cells producing GABA neurotransmitter have been discovered to have antidepressant effects similar to pharmaceutical antidepressants in depressed mice, giving new hope that GABA-enhancing drugs could be rapidly acting and more effective antidepressants.
Is sufficient sleep the key to successful antidepressant response?
Antidepressants are necessary for many with major depressive disorder, but response times and remission rates are a problem.

Related Antidepressant Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...